{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:26:49Z","timestamp":1789230409508,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Norwegian Cancer Society"},{"DOI":"10.13039\/501100005416","name":"The Norwegian Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ejca.2011.06.047","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T12:39:49Z","timestamp":1311424789000},"page":"2463-2470","source":"Crossref","is-referenced-by-count":71,"title":["How to switch from morphine or oxycodone to methadone in cancer patients? A randomised clinical phase II trial"],"prefix":"10.1016","volume":"47","author":[{"given":"K.","family":"Moksnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Rosland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8.","family":"Paulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Klepstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kaasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejca.2011.06.047_b0005","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/annonc\/mdp001","article-title":"Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes","volume":"20","author":"Breivik","year":"2009","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2011.06.047_b0010","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","article-title":"Prevalence of pain in patients with cancer: a systematic review of the past 40years","volume":"18","author":"van den Beuken-van Everdingen","year":"2007","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2011.06.047_b0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3959(95)00017-M","article-title":"Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study","volume":"63","author":"Zech","year":"1995","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.ejca.2011.06.047_b0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpainsymman.2006.10.015","article-title":"Symptom prevalence in patients with incurable cancer: a systematic review","volume":"34","author":"Teunissen","year":"2007","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"10.1016\/j.ejca.2011.06.047_b0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","article-title":"Morphine and alternative opioids in cancer pain: the EAPC recommendations","volume":"84","author":"Hanks","year":"2001","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2011.06.047_b0030","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","article-title":"Strategies to manage the adverse effects of oral morphine: an evidence-based report","volume":"19","author":"Cherny","year":"2001","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2011.06.047_b0035","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jpainsymman.2009.06.002","article-title":"Establishing \u2018best practices\u2019 for opioid rotation: conclusions of an expert panel","volume":"38","author":"Fine","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ejca.2011.06.047_b0185","series-title":"Oxford textbook of palliative medicine","year":"2009"},{"key":"10.1016\/j.ejca.2011.06.047_b0045","series-title":"Opioid analgesic therapy","author":"Fallon","year":"2010"},{"issue":"7","key":"10.1016\/j.ejca.2011.06.047_b0050","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1634\/theoncologist.11-7-765","article-title":"Clinical pharmacology and pharmacotherapy of opioid switching in cancer patients","volume":"11","author":"Ross","year":"2006","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.ejca.2011.06.047_b0055","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G","article-title":"Opioid rotation for cancer pain: rationale and clinical aspects","volume":"86","author":"Mercadante","year":"1999","journal-title":"Cancer"},{"issue":"1\u20132","key":"10.1016\/j.ejca.2011.06.047_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pain.2006.01.010","article-title":"Current evidence for a genetic modulation of the response to analgesics","volume":"121","author":"Lotsch","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.ejca.2011.06.047_b0065","first-page":"CD004847","article-title":"Opioid switching to improve pain relief and drug tolerability","volume":"3","author":"Quigley","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ejca.2011.06.047_b0070","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1526-4637.2008.00461.x","article-title":"A systematic review of opioid conversion ratios used with methadone for the treatment of pain","volume":"9","author":"Weschules","year":"2008","journal-title":"Pain Med"},{"issue":"5","key":"10.1016\/j.ejca.2011.06.047_b0190","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1067\/mcp.2002.128386","article-title":"Disposition of nasal, intravenous, and oral methadone in healthy volunteers","volume":"72","author":"Dale","year":"2002","journal-title":"Clin Pharmacol Ther"},{"issue":"4 Suppl","key":"10.1016\/j.ejca.2011.06.047_b0080","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00002508-200207001-00002","article-title":"Clinical pharmacology of opioids for pain","volume":"18","author":"Inturrisi","year":"2002","journal-title":"Clin J Pain"},{"issue":"6","key":"10.1016\/j.ejca.2011.06.047_b0085","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jpainsymman.2008.05.016","article-title":"Morphine\u2013methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors","volume":"37","author":"Benitez-Rosario","year":"2009","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"10.1016\/j.ejca.2011.06.047_b0090","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00520-003-0440-1","article-title":"Opioid plasma concentration during switching from morphine to methadone: preliminary data","volume":"11","author":"Mercadante","year":"2003","journal-title":"Supportive Care Cancer"},{"issue":"10","key":"10.1016\/j.ejca.2011.06.047_b0095","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1200\/JCO.1999.17.10.3307","article-title":"Rapid switching from morphine to methadone in cancer patients with poor response to morphine","volume":"17","author":"Mercadante","year":"1999","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2011.06.047_b0100","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1200\/JCO.2001.19.11.2898","article-title":"Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study","volume":"19","author":"Mercadante","year":"2001","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2011.06.047_b0105","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/cncr.24754","article-title":"Methadone initiation and rotation in the outpatient setting for patients with cancer pain","volume":"116","author":"Parsons","year":"2010","journal-title":"Cancer"},{"issue":"2\u20133","key":"10.1016\/j.ejca.2011.06.047_b0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0304-3959(96)03286-1","article-title":"An update on the clinical use of methadone for cancer pain","volume":"70","author":"Ripamonti","year":"1997","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.ejca.2011.06.047_b0115","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1167::AID-CNCR23>3.0.CO;2-3","article-title":"Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study","volume":"82","author":"Lawlor","year":"1998","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2011.06.047_b0120","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T","article-title":"Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine","volume":"78","author":"Bruera","year":"1996","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2011.06.047_b0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1008263910494","article-title":"Equianalgesic dose\/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences","volume":"9","author":"Ripamonti","year":"1998","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2011.06.047_b0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ftd.0000211827.03726.e4","article-title":"Pharmacokinetics and pharmacodynamics of methadone enantiomers in hospice patients with cancer pain","volume":"28","author":"Auret","year":"2006","journal-title":"Ther Drug Monit"},{"issue":"10","key":"10.1016\/j.ejca.2011.06.047_b0135","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1200\/JCO.1998.16.10.3216","article-title":"Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?","volume":"16","author":"Ripamonti","year":"1998","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2011.06.047_b0140","doi-asserted-by":"crossref","first-page":"536","DOI":"10.5694\/j.1326-5377.2000.tb139323.x","article-title":"The rediscovery of methadone for cancer pain management","volume":"173","author":"Ayonrinde","year":"2000","journal-title":"Med J Aust"},{"issue":"5","key":"10.1016\/j.ejca.2011.06.047_b0195","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0269216310384902","article-title":"European palliative care research collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review","volume":"25","author":"Dale","year":"2011","journal-title":"Palliat Med"},{"issue":"2","key":"10.1016\/j.ejca.2011.06.047_b0145","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"issue":"2","key":"10.1016\/j.ejca.2011.06.047_b0150","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/082585979100700202","article-title":"The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients","volume":"7","author":"Bruera","year":"1991","journal-title":"J Palliat Care"},{"issue":"7454","key":"10.1016\/j.ejca.2011.06.047_b0155","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ejca.2011.06.047_b0160","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jpainsymman.2007.12.024","article-title":"Frequency, indications, outcomes, and predictive factors of opioid switching in an Acute Palliative Care Unit","volume":"37","author":"Mercadante","year":"2009","journal-title":"J Pain Symptom Manage"},{"issue":"22","key":"10.1016\/j.ejca.2011.06.047_b0165","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1200\/JCO.2005.13.128","article-title":"Rapid switching between transdermal fentanyl and methadone in cancer patients","volume":"23","author":"Mercadante","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2011.06.047_b0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1191\/0269216306pm1099oa","article-title":"Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: a nine-month follow-up study","volume":"20","author":"Fredheim","year":"2006","journal-title":"Palliat Med"},{"issue":"2","key":"10.1016\/j.ejca.2011.06.047_b0175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1191\/0269216303pm696oa","article-title":"An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population","volume":"17","author":"Tse","year":"2003","journal-title":"Palliat Med"},{"key":"10.1016\/j.ejca.2011.06.047_b0180","first-page":"109","article-title":"Comments on Ripamonti et al.","volume":"70","author":"Morley","year":"1997","journal-title":"Pain"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804911004758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804911004758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T15:04:08Z","timestamp":1592751848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804911004758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":37,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0959804911004758"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2011.06.047","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}